View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Carole Braudeau
  • Carole Braudeau

Morning Crédit 14/11/2025

Ubisoft reporte la publication de ses résultats au S1 2025-26|Lufthansa: Germany heading towards a more favorable regulatory framework|

Carole Braudeau
  • Carole Braudeau

Credit Morning 11/14/2025

Ubisoft postpones the release of its H1 2025-26 results|Lufthansa: Germany heading towards a more favorable regulatory framework|

Mate Somlai-Kiss
  • Mate Somlai-Kiss

Waberer’s - Solid Results Bolster Confidence In FY Guidance

Waberer’s reported Q3/25 earnings today, once again delivering strong results. Quarterly EBIT came in at EUR 12.4mn (+23% YoY) on record quarterly revenues of EUR 205.4mn (+7.8%YoY). Logistics delivered a strong increase in EBIT on lower revenues, coming in at EUR 5.5mn (+53.4%YoY). Insurance EBIT came in at EUR 6.9mn, +6.3% higher than a year ago. The rapid efficiency improvement coming from the Posta Biztosítók acquisition helped deliver solid results, however, the higher-than-expected co...

Ghada Ben Sedrine ... (+2)
  • Ghada Ben Sedrine
  • Nicolas David
Ghada Ben Sedrine ... (+2)
  • Ghada Ben Sedrine
  • Nicolas David
Bruno Cavalier
  • Bruno Cavalier

The US economy after the shutdown: weaker and more uncertain

The federal government has reopened after a record 43-day shutdown. This is a political defeat for the Democrats, who gave in without getting anything in return. It is also a blow to economic activity. Real GDP growth could be close to zero in Q4, before recovering in Q1 2026. However, the return to normal will not be instantaneous, particularly for federal statistical agencies. Some data for October will probably not be computed, while other statistics will be published late and their quality w...

Post And Telecom Equipment Factory: 1 director

A director at Post And Telecom Equipment Factory sold 2,381,772 shares at 0.000VND and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the ...

 PRESS RELEASE

BTS Group AB appoints Nomination Committee

BTS Group AB appoints Nomination Committee P R E S S  R E L E A S E Stockholm, November 14, 2025 STOCKHOLM, SWEDEN - BTS GROUP AB (publ), a leading global consultancy specializing in strategy execution, change, and people development, has had a Nomination committee appointed for the company. BTS Group AB’s three largest shareholders have in consultation with the Chairman of the Board, Henrik Ekelund, appointed the following representatives to serve on the Nomination committee: Anders Dahl, representing Henrik EkelundHenrik Ekelund, Chairman of the Board, BTS Group ABClaes Murander, repre...

 PRESS RELEASE

BTS Group AB utser valberedning

BTS Group AB utser valberedning P R E S S R E L E A S E Stockholm den 14 november 2025 STOCKHOLM, SVERIGE - BTS GROUP AB (publ), ett ledande globalt konsultföretag inom strategigenomförande, förändring och medarbetarutveckling, meddelar att en valberedning har utsetts för bolaget. BTS tre största aktieägare har i samråd med styrelsens ordförande Henrik Ekelund utsett följande personer att ingå i valberedningen: Anders Dahl, utsedd av Henrik EkelundHenrik Ekelund, styrelseordförande, BTS Group ABClaes Murander, utsedd av Lannebo KapitalförvaltningStefan af Petersens, eget innehav Anders ...

 PRESS RELEASE

Form 8.5 (EPT/RI)-NCC Group plc

Form 8.5 (EPT/RI)-NCC Group plc FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) 1.        KEY INFORMATION (a)        Name of exempt principal trader:Investec Bank plc(b)        Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offereeNCC Group plc(c)        Name of the party to the offer with which exempt principal trader is connected:Investec is Joint Broker to NCC Grou...

Naver Co Ltd: 2 directors

Two Directors at Naver Co Ltd sold after exercising options/sold 1,046 shares at between 263,500.000KRW and 264,000.000KRW. The significance rating of the trade was 73/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by a...

Nedbank Limited: Update to credit analysis

Our credit view of Nedbank reflects its good liquidity, adequate capital, offset by elevated asset risks and a difficult operating environment. Advanced LGF analysis leads ratings higher.

Stockwik Forvaltning AB: 2 directors

A director at Stockwik Forvaltning AB sold 250,000 shares at 23.000SEK and the significance rating of the trade was 94/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...

ACS: ANUNCIA EL ACUERDO CON GIP PARA SU DIVISIÓN DIGITAL & ENERGÍA (AN...

Acaba de anunciar un acuerdo con GIP (propiedad de Blackrock) para crear una sociedad conjunta al 50% destinada a la promoción, construcción, desarrollo, operación y comercialización de una capacidad inicial de 1,7GW en centros de datos

Mathijs Geerts Danau
  • Mathijs Geerts Danau

Hyloris Positive results for IV Aspirin, NDA will be submitted

Hyloris announced positive topline results from a pivotal study in healthy volunteers for IV aspirin. The trial achieved all its targets, enabling progression towards submission of a New Drug Application (NDA) in 2026 and expected approval in 2027. IV Aspirin is intended to be used in acute coronary syndrome and is part of Hyloris's CV portfolio, for which Hyloris needs to announce a commercial partner in the US. We model € 52m peak sales by 2037. We reiterate our HOLD and € 6 TP.

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch